527 related articles for article (PubMed ID: 34497344)
1. Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice.
Lin CP; Huang PH; Chen CY; Wu MY; Chen JS; Chen JW; Lin SJ
Sci Rep; 2021 Sep; 11(1):17851. PubMed ID: 34497344
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin Attenuates Oxidative Stress, NF-κB Activation, and Artery Calcification in LDLR-/- Mice Fed with High Fat Diet via Down-regulation of Tumor Necrosis Factor-α and TNF Receptor 1.
Lin CP; Huang PH; Lai CF; Chen JW; Lin SJ; Chen JS
PLoS One; 2015; 10(12):e0143686. PubMed ID: 26625143
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant agent DPP4 inhibitor sitagliptin downregulates CXCR3/RAGE pathway on seizure models.
Liu Y; Hou B; Zhang Y; Fan Y; Peng B; Liu W; Han S; Yin J; He X
Exp Neurol; 2018 Sep; 307():90-98. PubMed ID: 29885296
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products promote human aortic smooth muscle cell calcification in vitro via activating NF-κB and down-regulating IGF1R expression.
Wang Y; Zhang ZY; Chen XQ; Wang X; Cao H; Liu SW
Acta Pharmacol Sin; 2013 Apr; 34(4):480-6. PubMed ID: 23416929
[TBL] [Abstract][Full Text] [Related]
6. Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes.
Brodeur MR; Bouvet C; Bouchard S; Moreau S; Leblond J; Deblois D; Moreau P
PLoS One; 2014; 9(1):e85922. PubMed ID: 24465790
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin on AGEs-induced injury of cerebral cortex via inhibiting NADPH oxidase -NF-κB pathway in ApoE
Li Z; Yang P; Feng B
Mol Biol Rep; 2020 Dec; 47(12):9479-9488. PubMed ID: 33210255
[TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end products modulates oxidative stress and mitochondrial function in the soleus muscle of mice fed a high-fat diet.
Velayoudom-Cephise FL; Cano-Sanchez M; Bercion S; Tessier F; Yu Y; Boulanger E; Neviere R
Appl Physiol Nutr Metab; 2020 Oct; 45(10):1107-1117. PubMed ID: 32289236
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
10. The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification.
Kay AM; Simpson CL; Stewart JA
J Diabetes Res; 2016; 2016():6809703. PubMed ID: 27547766
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus accelerates cartilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant mice.
Nguyen N; Naik V; Speer MY
Cardiovasc Pathol; 2013; 22(2):167-75. PubMed ID: 22818582
[TBL] [Abstract][Full Text] [Related]
12. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E-deficient mice.
Li B; Luo YR; Zhang Q; Fu SH; Chen YD; Tian JW; Guo Y
Vascul Pharmacol; 2021 Oct; 140():106854. PubMed ID: 33781961
[TBL] [Abstract][Full Text] [Related]
13. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end product-modified low-density lipoprotein promotes pro-osteogenic reprogramming via RAGE/NF-κB pathway and exaggerates aortic valve calcification in hamsters.
Yang X; Zeng J; Xie K; Su S; Guo Y; Zhang H; Chen J; Ma Z; Xiao Z; Zhu P; Zheng S; Xu D; Zeng Q
Mol Med; 2024 Jun; 30(1):76. PubMed ID: 38840067
[TBL] [Abstract][Full Text] [Related]
15. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.
Belmokhtar K; Ortillon J; Jaisson S; Massy ZA; Boulagnon Rombi C; Doué M; Maurice P; Fritz G; Gillery P; Schmidt AM; Rieu P; Touré F
Nephrol Dial Transplant; 2019 Dec; 34(12):2018-2030. PubMed ID: 30778553
[TBL] [Abstract][Full Text] [Related]
16. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
[TBL] [Abstract][Full Text] [Related]
17. Swertiamarin mitigates nephropathy in high-fat diet/streptozotocin-induced diabetic rats by inhibiting the formation of advanced glycation end products.
Parwani K; Patel F; Bhagwat P; Dilip H; Patel D; Thiruvenkatam V; Mandal P
Arch Physiol Biochem; 2024 Apr; 130(2):136-154. PubMed ID: 34657540
[TBL] [Abstract][Full Text] [Related]
18. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis.
Uekita H; Ishibashi T; Shiomi M; Koyama H; Ohtsuka S; Yamamoto H; Yamagishi S; Inoue H; Itabe H; Sugimoto K; Kamioka M; Ohkawara H; Wada I; Yasuchika T
Fukushima J Med Sci; 2019; 65(3):109-121. PubMed ID: 31915324
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.
Ishibashi Y; Matsui T; Maeda S; Higashimoto Y; Yamagishi S
Cardiovasc Diabetol; 2013 Aug; 12():125. PubMed ID: 23984879
[TBL] [Abstract][Full Text] [Related]
20. Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells.
Suga T; Iso T; Shimizu T; Tanaka T; Yamagishi S; Takeuchi M; Imaizumi T; Kurabayashi M
J Atheroscler Thromb; 2011; 18(8):670-83. PubMed ID: 21512281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
